Publications

1. Zheng D, Trynda J, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Sexual dimorphism in the incidence of human cancers. BMC Cancer. 2019 Jul 12; 19 (1):684 Epub 2019 July 12
   View PubMed
2. Zheng D, Trynda J, Sun Z, Li Z. NUCLIZE for quantifying epigenome: generating histone modification data at single-nucleosome resolution using genuine nucleosome positions. BMC Genomics. 2019 Jul 2; 20 (1):541 Epub 2019 July 02
   View PubMed
3. Zheng D, McLaughlin SA, Kaestner KH, Li Z. Genetic ablation of mammary ducts through foxa1 prevents breast cancer occurrence. Am J Cancer Res. 2019; 9 (2):424-428 Epub 2019 Feb 01
   View PubMed
4. Zheng D, Li Z. A sex-dimorphic mouse model of esophageal squamous cell carcinoma. Am J Cancer Res. 2019; 9 (2):429-433 Epub 2019 Feb 01
   View PubMed
5. Zheng D, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Lett. 2018 Dec 1; 438:24-31 Epub 2018 Sept 14
   View PubMed
6. Xu Y, Lee JH, Li Z, Wang L, Ordog T, Bailey RC. A droplet microfluidic platform for efficient enzymatic chromatin digestion enables robust determination of nucleosome positioning. Lab Chip. 2018 Aug 21; 18 (17):2583-2592
   View PubMed
7. Zheng D, Wang X, Antonson P, Gustafsson JA, Li Z. Genomics of sex hormone receptor signaling in hepatic sexual dimorphism. Mol Cell Endocrinol. 2018 Aug 15; 471:33-41 Epub 2017 May 26
   View PubMed
8. Wang X, Antonson P, Gustafsson J, Li Z. Genomics of sex hormone receptor signaling in hepatic sexual dimorphism Molecular and Cellular Endocrinology Molecular and Cellular Endocrinology.2017;().
   
9. Liu Y, Zhao Y, Skerry B, Wang X, Colin-Cassin C, Radisky DC, Kaestner KH, Li Z. Foxa1 is essential for mammary duct formation. Genesis. 2016 May; 54 (5):277-85 Epub 2016 Mar 29
   View PubMed
10. Zhang G, Zhao Y, Liu Y, Kao LP, Wang X, Skerry B, Li Z. FOXA1 defines cancer cell specificity. Sci Adv. 2016 Mar; 2 (3):e1501473 Epub 2016 Mar 18
    View PubMed
11. Zhao Y, Li Z. NUCLIZE-MAP: Visualization of nucleosome mapping data and NUCLIZE-analyzed data (database) http://nuclize.mayo.edu (NIH Roadmap Epigenomics Project).2016;
    
12. Zhao Y, Li Z. Interplay of estrogen receptors and FOXA factors in the liver cancer. Mol Cell Endocrinol. 2015 Dec 15; 418 Pt 3:334-9 Epub 2015 Feb 04
    View PubMed
13. Zhao Y, Li Z. NUCLIZE: defining histone variants and modification at the single nucleosome resolution http://nuclize.mayo.edu.2015;
    
14. Jiao Y, Ye DZ, Li Z, Teta-Bissett M, Peng Y, Taub R, Greenbaum LE, Kaestner KH. Protein tyrosine phosphatase of liver regeneration-1 is required for normal timing of cell cycle progression during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2015 Jan 15; 308: (2)G85-91.
    View PubMed
15. Chen K, Xi Y, Pan X, Li Z, Kaestner K, Tyler J, Dent S, He X, Li W. DANPOS: Dynamic Analysis of Nucleosome Position and Occupancy by Sequencing. Genome Res .23:(2):341-51.
    View PubMed
16. Li Z, Gadue P, Chen K, Jiao Y, Tuteja G, Schug J, Li W, Kaestner K. Foxa2 and H2A.Z mediate nucleosome depletion during ES cell differentiation. Cell.2012 December 21;151:(7):1608-1616.
    View PubMed
17. Rieck S, Zhang J, Li Z, Liu C, Naji A, Takane KK, Fiaschi-Taesch NM, Stewart AF, Kushner JA, Kaestner KH. Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets. Mol Endocrinol. 2012 Sep; 26(9):1590-602. Epub 2012 Jul 13.
    View PubMed
18. Li Z, Tuteja G, Schug J, Kaestner KH. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell. 2012 Jan 20; 148(1-2):72-83.
    View PubMed
19. Li Z, Schug J, Tuteja G, White P, Kaestner KH. The nucleosome map of the mammalian liver. Nat Struct Mol Biol. 2011 Jun; 18(6):742-6. Epub 2011 May 29.
    View PubMed
20. Soccio RE, Tuteja G, Everett LJ, Li Z, Lazar MA, Kaestner KH. Species-specific strategies underlying conserved functions of metabolic transcription factors. Mol Endocrinol. 2011 Apr; 25(4):694-706. Epub 2011 Feb 03.
    View PubMed
21. Li Z, Agellon LB, Vance DE. The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis. Biochim Biophys Acta. 2011 Apr; 1811(4):278-83. Epub 2011 Feb 1.
    View PubMed
22. Li Z, White P, Tuteja G, Rubins N, Sackett S, Kaestner KH. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest. 2009 Jun; 119(6):1537-45. Epub 2009 May 11
    View PubMed
23. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008 Jun; 49(6):1187-94. Epub 2008 Jan 19.
    View PubMed
24. Vance DE, Li Z, Jacobs RL. Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology. J Biol Chem. 2007 Nov 16; 282(46):33237-41. Epub 2007 Sep 19.
    View PubMed
25. Li Z, Agellon LB, Vance DE. A role for high density lipoproteins in hepatic phosphatidylcholine homeostasis. Biochim Biophys Acta. 2007 Jul; 1771(7):893-900. Epub 2007 Apr 21.
    View PubMed
26. Li Z, Agellon LB, Vance DE. Choline redistribution during adaptation to choline deprivation. J Biol Chem. 2007 Apr 6; 282(14):10283-9. Epub 2007 Feb 05.
    View PubMed
27. Li Z, Vance DE. Choline cannot be replaced by propanolamine in mice. Biochim Biophys Acta. 2007 Apr; 1771(4):486-90. Epub 2007 Jan 10.
    View PubMed
28. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, Vance DE. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006 May; 3(5):321-31.
    View PubMed
29. Li Z, Agellon LB, Vance DE. Phosphatidylcholine homeostasis and liver failure. J Biol Chem. 2005 Nov 11; 280(45):37798-802. Epub 2005 Sep 06.
    View PubMed